UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre

PloS one, 2023-01, Vol.18 (1), p.e0279883-e0279883

2023

Volltextzugriff (PDF)

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer

PloS one, 2022-08, Vol.17 (8), p.e0271981-e0271981

2022

Volltextzugriff (PDF)

An update on enzalutamide in the treatment of prostate cancer

Therapeutic Advances in Urology, 2015-02, Vol.7 (1), p.9-21

2015

Volltextzugriff (PDF)

Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer

BMC cancer, 2020-02, Vol.20 (1), p.140-140, Article 140

2020

Volltextzugriff (PDF)

Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer

European journal of nuclear medicine and molecular imaging, 2017-06, Vol.44 (6), p.960-968

2017

Volltextzugriff (PDF)

Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study

Journal of Nuclear Medicine, 2020-11, Vol.61 (11), p.1602-1606

2020

Volltextzugriff (PDF)

Re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.03.042

European urology, 2017-10, Vol.72 (4), p.e98-e99

2017

Volltextzugriff (PDF)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers

BMC cancer, 2021-04, Vol.21 (1), p.444-444, Article 444

2021

Volltextzugriff (PDF)

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

Strahlentherapie und Onkologie, 2020-11, Vol.196 (11), p.1006-1017

2020

Volltextzugriff (PDF)

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities

Strahlentherapie und Onkologie, 2020-07, Vol.196 (7), p.598-607

2020

Volltextzugriff (PDF)

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer

Frontiers in oncology, 2021-04, Vol.11, p.664225-664225

2021

Volltextzugriff (PDF)

Comment on: “Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years”

World journal of urology, 2016-05, Vol.34 (5), p.763-764

2016

Volltextzugriff (PDF)

Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature

Frontiers in oncology, 2020-05, Vol.10, p.808-808

2020

Volltextzugriff (PDF)

Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer

Strahlentherapie und Onkologie, 2019-05, Vol.195 (5), p.420-429

2019

Volltextzugriff (PDF)

Is there an anti-androgen withdrawal syndrome for enzalutamide?

World journal of urology, 2014-10, Vol.32 (5), p.1171-1176

2014

Volltextzugriff (PDF)

Patterns of Progression After 68 Ga-PSMA-Ligand PET/CT-Guided Radiation Therapy for Recurrent Prostate Cancer

International journal of radiation oncology, biology, physics, 2019-01, Vol.103 (1), p.95

2019

Volltextzugriff (PDF)

Can we predict the clinical outcome of patients with bladder trauma?

World journal of urology, 2013-08, Vol.31 (4), p.1017-1018

2013

Volltextzugriff (PDF)

Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy

Urologia internationalis, 2023-02, Vol.107 (2), p.126-133

2023

Volltextzugriff (PDF)

Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study

Prostate cancer and prostatic diseases, 2024-04

2024

Volltextzugriff (PDF)

Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis

European urology, 2015-08, Vol.68 (2), p.317-324

2015

Volltextzugriff (PDF)

En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor

World journal of urology, 2015-12, Vol.33 (12), p.1937-1943

2015

Volltextzugriff (PDF)

DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients

Oncology reports, 2018-12, Vol.40 (6), p.3861-3868

2018

Volltextzugriff (PDF)

Androgen deprivation therapy as backbone therapy in the management of prostate cancer

OncoTargets and therapy, 2016-01, Vol.9, p.7263-7274

2016

Volltextzugriff (PDF)

(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy

Strahlentherapie und Onkologie, 2016-07, Vol.192 (7), p.431-439

2016

Volltextzugriff (PDF)

Influence of short-term dexamethasone on the efficacy of 177 Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

The Prostate, 2020-05, Vol.80 (8), p.619-631

2020

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(108)
Berichte
(1)

Sprache

Englisch
(106)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer

An update on enzalutamide in the treatment of prostate cancer

Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer

Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer

Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study

Re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.03.042

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer

Comment on: “Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years”

Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature

Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer

Is there an anti-androgen withdrawal syndrome for enzalutamide?

Patterns of Progression After 68 Ga-PSMA-Ligand PET/CT-Guided Radiation Therapy for Recurrent Prostate Cancer

Can we predict the clinical outcome of patients with bladder trauma?

Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy

Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study

Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis

En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor

DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients

Androgen deprivation therapy as backbone therapy in the management of prostate cancer

(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy

Influence of short-term dexamethasone on the efficacy of 177 Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

Suchergebnisse filtern